Beconase Hayfever Relief for Adults 0.05% Nasal Spray (100)

Product summary

Beconase Hayfever Relief for Adults Nasal Spray for the treatment of hay fever

Beconase Hayfever Relief for Adults is a long-lasting non-drowsy nasal spray which gets to work quickly, unlike tablets, by working directly in the nose where symptoms start.

Beconase Hayfever Relief for Adults Nasal Spray has an anti-inflammatory action which is highly effective at quickly relieving allergy-related symptoms such as nasal congestion, watery eyes, runny nose, sneezing, itchy eyes, itchy nose, red eyes and sinus discomfort.

Beconase Hayfever Relief for Adults Nasal Spray

Long-lasting, effective relief from hay fever symptoms

How to use

Please read the enclosed leaflet carefully before use.

Shake gently before use.

• Adults aged 18 or over: two sprays into each nostril every morning and evening
• Once symptoms have improved, you may be able to reduce the dose to one spray into each nostril morning and evening.
• Use only in the nose.
• Use regularly.

Ingredients

• Active ingredients: Beclometasone Dipropionate 50 micrograms per spray
• Other ingredients: Microcrystalline Cellulose, Sodium Carboxymethylcellulose, Dextrose, Polysorbate 80, Purified Water, Preservatives: Benzalkonium Chloride, Phenylethylalcohol

Warnings and restrictions

Not for use by children or adolescents under 18 years.

See your doctor before use if:

• you are pregnant or breastfeeding, or planning to become pregnant.
• you are currently taking another steroid.
• you suffer from nosebleeds
• you have recently had surgery or an injury to your nose.
• your symptoms have not improved after using the spray for 7 days.

DO NOT USE more than 4 sprays in each nostril in a day.

Do not use for more than one month continuously without consulting your doctor.

Do not use if you are sensitive to any of the ingredients.

Speak to your doctor or pharmacist if you have an underlying medical condition, are taking any other medication or complementary therapy, or if symptoms persist.